MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

MDT

95.62

+0.66%↑

VEEV

283

-3.27%↓

A

141.9

+0.66%↑

HQY

91.19

+0.35%↑

TLRY

1.55

+1.31%↑

Search

Microbot Medical Inc

Uždarymo kaina

2.75 -2.48

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.68

Max

2.82

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-899K

-3.5M

Pelno marža

-4,038.095

Darbuotojai

20

EBITDA

-84K

-3.5M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+322.54% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-11-12

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

31M

159M

Ankstesnė atidarymo kaina

5.23

Ankstesnė uždarymo kaina

2.75

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-10-17 18:13; UTC

Pagrindinės rinkos jėgos

Revolution Medicines Rises as FDA Grants Priority Designation for Cancer Treatment

2025-10-17 17:05; UTC

Pagrindinės rinkos jėgos

Artiva Biotherapeutics Shares Jump After Treatment Gets Fast Tracked

2025-10-17 15:03; UTC

Pagrindinės rinkos jėgos

Obook Shares Sink Following Public Debut

2025-10-17 14:41; UTC

Pagrindinės rinkos jėgos

Disc Medicine Shares Surge After FDA Grants Priority Voucher for EPP Drug

2025-10-17 23:25; UTC

Įsigijimai, susijungimai, perėmimai

New Zealand's 'Golden Visa' Targets the Affluent in Search of Plan B -- Barrons.com

2025-10-17 22:15; UTC

Rinkos pokalbiai

Ulta's CFO Appointment Seen Supporting Growth -- Market Talk

2025-10-17 21:15; UTC

Rinkos pokalbiai

Greece Expected to Post Overall Budgetary Surplus This Year -- Market Talk

2025-10-17 21:07; UTC

Rinkos pokalbiai

Oracle Stock Expected to Take a Breather as Capex Climbs -- Market Talk

2025-10-17 21:07; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-17 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-17 20:34; UTC

Rinkos pokalbiai

Deere Is Reaching the End of Its Downcycle -- Market Talk

2025-10-17 20:27; UTC

Rinkos pokalbiai

Soft Growth Ahead in Canada But Not Far Off From Potential GDP, Macklem Says -- Market Talk

2025-10-17 19:46; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

2025-10-17 19:45; UTC

Rinkos pokalbiai

Oil Futures Stabilize, But End Week With A Loss -- Market Talk

2025-10-17 18:45; UTC

Rinkos pokalbiai

Treasury Yields, Dollar Try to Reclaim Some Ground -- Market Talk

2025-10-17 17:51; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-17 17:51; UTC

Rinkos pokalbiai

Euro Still a Long Way From Supplanting Dollar, Former ECB Rate Setter Says -- Market Talk

2025-10-17 17:44; UTC

Rinkos pokalbiai

EQT Seen With Long-Term Growth Opportunities -- Market Talk

2025-10-17 17:35; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Unchanged at 418 -- Market Talk

2025-10-17 16:20; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-10-17 16:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-10-17 16:14; UTC

Rinkos pokalbiai

Home Depot Will Gain From Pick Up in Home Improvement Activity -- Market Talk

2025-10-17 16:04; UTC

Rinkos pokalbiai

Home Improvement Demand Is Starting to Pick Up -- Market Talk

2025-10-17 15:58; UTC

Rinkos pokalbiai

Amazon's Project Rainier Will Begin to Stem Its AI Share Losses -- Market Talk

2025-10-17 15:56; UTC

Uždarbis

These Stocks Are Moving the Most Today: Zions Bancorp, Jefferies, Amex, Oracle, Novo Nordisk, Lilly, State Street, CSX, and More -- Barrons.com

2025-10-17 15:43; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-10-17 15:43; UTC

Rinkos pokalbiai

Amazon's Earnings Are About Sentiment of Consumers, Not Investors -- Market Talk

2025-10-17 14:58; UTC

Rinkos pokalbiai

Small-Business Trepidation in Canada Points to Economic Decline -- Market Talk

2025-10-17 14:41; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-10-17 14:35; UTC

Rinkos pokalbiai
Uždarbis

American Express's Delayed Card Fee Hike Worries Some Investors -- Market Talk

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

322.54% į viršų

12 mėnesių prognozė

Vidutinis 12 USD  322.54%

Aukščiausias 12 USD

Žemiausias 12 USD

Remiantis 1 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

1 ratings

1

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Very Strong Bullish Evidence

Ilgalaikis periodas

Weak Bullish Evidence

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.
help-icon Live chat